Forecast Period 
Market Size (Base Year) 
Market Size (Forecast Year)
CAGRGlobal lmmunohistochemistry (IHC) Reagents and Kits Market, By Product (Antibodies, Equipment, Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Reagents, Chromogenic Substrates, Historical Stains, Organic Solvent, Stabilizers, Kits, Others), Applications (Diagnostics, Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, Drug Testing, Nephrological Diseases), End Users (Hospitals, Diagnostic Laboratories, Research Institutes, Others) – Industry Trends and Forecast to 2029
lmmunohistochemistry (IHC) Reagents and Kits Market Analysis and Size
The immunohistochemistry (IHC) sector will experience tremendous growth due to the rise in the prevalence of chronic diseases and the increase in drug research activities. In addition to this, the enormous need for diagnosing cancer, heart conditions, and other viral illnesses like Swine Flu, Bird Flu, and COVID has revealed the importance of immunohistochemistry in the healthcare industry, unleashing market trends. Additionally, over the course of the assessment period, the growth of the immunohistochemistry (IHC) business will be influenced by regulatory approvals as well as the introduction of new products.
Data Bridge Market Research analyses that the immunohistochemistry (IHC) reagents and kits market which was USD 2.3 billion in 2021, would rocket up to USD 4.18 billion by 2029, and is expected to undergo a CAGR of 7.75% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
lmmunohistochemistry (IHC) Reagents and Kits Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2014 - 2019) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product (Antibodies, Equipment, Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Reagents, Chromogenic Substrates, Historical Stains, Organic Solvent, Stabilizers, Kits, Others), Applications (Diagnostics, Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, Drug Testing, Nephrological Diseases), End Users (Hospitals, Diagnostic Laboratories, Research Institutes, Others) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
F. Hoffman-La Roche AG (Switzerland), Danaher (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Bio-Techne Corporation (U.S.), Abcam plc (U.K.), BD (U.S.), PerkinElmer, Inc. (U.S.), Takara Bio, Inc. (Japan), Thermo Fisher Scientific, Inc. (U.S.), PHC Holdings Corporation (Japan), Cell Signaling Technology, Inc. (U.S.), Bio SB, Inc. (U.S.), Miltenyi Biotec (Germany), CANDOR Bioscience GmbH (Germany), Sakura Finetek Japan Co. Ltd. (Japan), Eagle Biosciences, Inc. (U.S.), Biocare Medical, LLC (U.S.), Elabscience, Inc. (China) |
|
Market Opportunities |
|
Market Definition
Immunohistochemistry, also known as IHC, is a method that effectively utilises monoclonal and polyclonal antibodies to identify certain antigens in tissues, consequently identifying various diseases in individuals. The IHC approach is broken down into two phases: analysing and quantifying the resulting gene expression and first, preparation of the slides and stages involved in the reaction. Additionally, immunohistochemistry is essential for scientific research projects and the interpretation of differential diagnoses that cannot be made with the aid of eosin and hematoxylin in traditional analysis. In pathology, it is mostly used in the fields of hematopathology, oncologic pathology, and neuropathology. Additionally, immunohistochemistry combines histology and immunology.
lmmunohistochemistry (IHC) Reagents and Kits Market Dynamics
Drivers
- Increasing incidence of chronic diseases and technological advancements in IHC
The growing incidence and prevalence of cancer, technical progressions in IHC, and the availability of reimbursement for IHC tests are the major factors driving the growth of this market.
- Rise in chronic diseases
The market's expansion is mostly fuelled by the ageing population's increased prevalence of chronic and infectious diseases, the development of IHC technology, and the availability of IHC test reimbursements.
Opportunities
- Increase in the number of research and development activities
The market's growth is fuelled by rise in the diagnostic units and clinics along with rise in the cases of life-threatening ailments will propell the expansion of immunohistochemistry (IHC) market over 2022-2029. This will provide beneficial opportunities for the market growth.
Restraints/Challenges
- High cost
On the other hand, high setup cost is increasing burden on end users such as diagnostic centers or hospitals will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the market.
- High degree of consolidation
High degree of consolidation by the major market players is expected to restrain the growth of this market during the forecast period.
This immunohistochemistry (IHC) reagents and kits market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the immunohistochemistry (IHC) reagents and kits market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on lmmunohistochemistry (IHC) Reagents and Kits Market
The COVID-19 epidemic had a positive impact on the market. Whereas in the outbreak of pandemic like COVID-19 where doctors are unable to understand the reason behind disease spread properly it becomes crucial to move towards these applications which boost the growth of market.
Recent Development
- In March 2020, Visiopharm and Agilent Technologies Inc., two biotechnology companies, announced a collaboration to market their histology tests for cancer patient testing and pathology and to develop a better solution for the cancer diagnosis market.
- In June 2019, PHC Holding bought Thermo Fisher Scientific, Inc.'s Anatomical Pathology division, which sells IHC products.
- In August 2019, The one and only vitro diagnostic ROS1 IHC assay was introduced by Roche with the VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody.
Global lmmunohistochemistry (IHC) Reagents and Kits Market Scope
The immunohistochemistry (IHC) reagents and kits market is segmented on the basis of product, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Antibodies
- Equipment
- Slide Staining Systems
- Tissue Microarrays
- Tissue Processing Systems
- Slide Scanners
- Reagents
- Chromogenic Substrates
- Historical Stains
- Organic Solvent
- Stabilizers
- Kits
- Others
Applications
- Diagnostics
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Drug Testing
- Nephrological Diseases
End Users
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Others
lmmunohistochemistry (IHC) Reagents and Kits Market Regional Analysis/Insights
The immunohistochemistry (IHC) reagents and kits market is analysed and market size insights and trends are provided by country, product, application and end-user as referenced above.
The countries covered in the immunohistochemistry (IHC) reagents and kits market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the immunohistochemistry (IHC) reagents and kits market due to the increasing pressure on better healthcare infrastructure and more investment in healthcare sector.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the large population in emerging economies such as China, India, and Japan, rising prevalence of chronic diseases; rising demand for quality medical care; and the increasing healthcare spending are expected to boost the immunohistochemistry (IHC) reagents and kits market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The immunohistochemistry (IHC) reagents and kits market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for immunohistochemistry (IHC) reagents and kits market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the immunohistochemistry (IHC) reagents and kits market. The data is available for historic period 2010-2020.
Competitive Landscape and lmmunohistochemistry (IHC) Reagents and Kits Market Share Analysis
The immunohistochemistry (IHC) reagents and kits market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to immunohistochemistry (IHC) reagents and kits market.
Some of the major players operating in the immunohistochemistry (IHC) reagents and kits market are:
- F. Hoffman-La Roche AG (Switzerland)
- Danaher (U.S.)
- Agilent Technologies, Inc. (U.S.)
- Merck KGaA (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- Bio-Techne Corporation (U.S.)
- Abcam plc (U.K.)
- BD (U.S.)
- PerkinElmer, Inc. (U.S.)
- Takara Bio, Inc. (Japan)
- Thermo Fisher Scientific, Inc. (U.S.)
- PHC Holdings Corporation (Japan)
- Cell Signaling Technology, Inc. (U.S.)
- Bio SB, Inc. (U.S.)
- Miltenyi Biotec (Germany)
- CANDOR Bioscience GmbH (Germany)
- Sakura Finetek Japan Co. Ltd. (Japan)
- Eagle Biosciences, Inc. (U.S.)
- Biocare Medical, LLC (U.S.)
- Elabscience, Inc. (China)
SKU-
